Agnès Basseville

696 total citations
18 papers, 521 citations indexed

About

Agnès Basseville is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Agnès Basseville has authored 18 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Agnès Basseville's work include Histone Deacetylase Inhibitors Research (7 papers), Protein Degradation and Inhibitors (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Agnès Basseville is often cited by papers focused on Histone Deacetylase Inhibitors Research (7 papers), Protein Degradation and Inhibitors (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Agnès Basseville collaborates with scholars based in United States, France and Denmark. Agnès Basseville's co-authors include Susan E. Bates, Antonio Tito Fojo, Laleh Amiri‐Kordestani, Karen Kurdziel, Robert W. Robey, Arup R. Chakraborty, Victoria Luchenko, Zhirong Zhan, Sophie de Carné Trécesson and Olivier Coqueret and has published in prestigious journals such as Nature Communications, Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

Agnès Basseville

17 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agnès Basseville United States 11 321 239 56 39 35 18 521
Mário Šereš Slovakia 13 337 1.0× 261 1.1× 77 1.4× 32 0.8× 18 0.5× 26 536
Clara Lemos Netherlands 9 451 1.4× 297 1.2× 39 0.7× 33 0.8× 22 0.6× 10 698
Yue-Li Sun China 10 248 0.8× 230 1.0× 70 1.3× 42 1.1× 40 1.1× 23 535
Parul Gupta India 11 260 0.8× 185 0.8× 65 1.2× 36 0.9× 42 1.2× 41 582
Jean Sargent United States 13 348 1.1× 211 0.9× 82 1.5× 24 0.6× 36 1.0× 28 601
Suhlan Wu United States 11 356 1.1× 158 0.7× 52 0.9× 38 1.0× 25 0.7× 11 516
Nagaraju Anreddy United States 13 249 0.8× 279 1.2× 36 0.6× 16 0.4× 43 1.2× 15 457
Yang-Hui Huang Taiwan 12 302 0.9× 308 1.3× 38 0.7× 18 0.5× 29 0.8× 29 479
Yoshihiko Shibayama Japan 11 239 0.7× 139 0.6× 144 2.6× 20 0.5× 28 0.8× 26 445
Lenka Gibalová Slovakia 9 233 0.7× 200 0.8× 49 0.9× 18 0.5× 11 0.3× 12 379

Countries citing papers authored by Agnès Basseville

Since Specialization
Citations

This map shows the geographic impact of Agnès Basseville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnès Basseville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnès Basseville more than expected).

Fields of papers citing papers by Agnès Basseville

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnès Basseville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnès Basseville. The network helps show where Agnès Basseville may publish in the future.

Co-authorship network of co-authors of Agnès Basseville

This figure shows the co-authorship network connecting the top 25 collaborators of Agnès Basseville. A scholar is included among the top collaborators of Agnès Basseville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnès Basseville. Agnès Basseville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jézéquel, Pascal, Hamza Lasla, Wilfried Gouraud, et al.. (2024). Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype. Breast Cancer. 31(5). 825–840. 3 indexed citations
2.
Scotto, Luigi, Agnès Basseville, Thomas Litman, et al.. (2023). Abstract LB_C03: Protein translation inhibition enforces histone deacetylase inhibitor activity resulting in synergistic pancreatic cancer cell death. Molecular Cancer Therapeutics. 22(12_Supplement). LB_C03–LB_C03. 1 indexed citations
3.
Basseville, Agnès, Wilfried Gouraud, Hamza Lasla, et al.. (2022). Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy. Cancer Research Communications. 2(8). 857–869. 2 indexed citations
4.
Basseville, Agnès, et al.. (2022). Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties. Cell Death and Disease. 13(9). 787–787. 13 indexed citations
5.
Basseville, Agnès, Pierre-Christian Violet, Carole Sourbier, et al.. (2022). A Histone Deacetylase Inhibitor Induces Acetyl-CoA Depletion Leading to Lethal Metabolic Stress in RAS-Pathway Activated Cells. Cancers. 14(11). 2643–2643. 6 indexed citations
6.
Litman, Thomas, Robert W. Robey, Andrés Aguilera, et al.. (2021). R-Loop–Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin. Molecular Cancer Research. 19(8). 1361–1374. 19 indexed citations
7.
Jézéquel, Pascal, Wilfried Gouraud, Agnès Basseville, et al.. (2021). Intérêt de l’outil web bc-GenExMiner en oncologie. Bulletin du Cancer. 108(11). 1057–1064.
8.
Trécesson, Sophie de Carné, Frédérique Souazé, Agnès Basseville, et al.. (2017). BCL-XL directly modulates RAS signalling to favour cancer cell stemness. Nature Communications. 8(1). 1123–1123. 41 indexed citations
9.
Robey, Robert W., Victoria Luchenko, Agnès Basseville, et al.. (2016). Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. Oncotarget. 7(43). 69804–69815. 12 indexed citations
10.
Serrano, Oscar K., et al.. (2015). Antitumor effect of pharmacologic ascorbate in the B16 murine melanoma model. Free Radical Biology and Medicine. 87. 193–203. 21 indexed citations
11.
Basseville, Agnès, Susan E. Bates, & Tito Fojo. (2015). Targeting KRAS and the vitamin D receptor via microtubules. Nature Reviews Clinical Oncology. 12(8). 442–444. 4 indexed citations
12.
Basseville, Agnès, Carole Sourbier, Robert W. Robey, et al.. (2015). Abstract 1771: Metabolic reprogramming in KRAS mutant cancer cells may cause sensitivity to the histone deacetylase (HDAC) inhibitor romidepsin. Cancer Research. 75(15_Supplement). 1771–1771. 1 indexed citations
13.
Ieranò, Caterina, Agnès Basseville, Kenneth K.W. To, et al.. (2013). Histone deacetylase inhibitors induce CXCR4 mRNA but antagonize CXCR4 migration. Cancer Biology & Therapy. 14(2). 175–183. 11 indexed citations
14.
Basseville, Agnès, Akina Tamaki, Caterina Ieranò, et al.. (2012). Histone Deacetylase Inhibitors Influence Chemotherapy Transport by Modulating Expression and Trafficking of a Common Polymorphic Variant of the ABCG2 Efflux Transporter. Cancer Research. 72(14). 3642–3651. 32 indexed citations
15.
Amiri‐Kordestani, Laleh, Agnès Basseville, Karen Kurdziel, Antonio Tito Fojo, & Susan E. Bates. (2012). Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies. Drug Resistance Updates. 15(1-2). 50–61. 176 indexed citations
16.
Basseville, Agnès, Laurence Preisser, Sophie de Carné Trécesson, et al.. (2011). Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells. Molecular Cancer. 10(1). 80–80. 47 indexed citations
17.
Basseville, Agnès & Susan E. Bates. (2011). Gout, genetics and ABC transporters. F1000 Biology Reports. 3. 23–23. 21 indexed citations
18.
Robey, Robert W., Arup R. Chakraborty, Agnès Basseville, et al.. (2011). Histone Deacetylase Inhibitors: Emerging Mechanisms of Resistance. Molecular Pharmaceutics. 8(6). 2021–2031. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mário Šereš Breakdown of academic impact, for papers by Clara Lemos Breakdown of academic impact, for papers by Yue-Li Sun Breakdown of academic impact, for papers by Parul Gupta Breakdown of academic impact, for papers by Jean Sargent Breakdown of academic impact, for papers by Suhlan Wu Breakdown of academic impact, for papers by Nagaraju Anreddy Breakdown of academic impact, for papers by Yang-Hui Huang Breakdown of academic impact, for papers by Yoshihiko Shibayama Breakdown of academic impact, for papers by Lenka Gibalová
Rankless by CCL
2026